John Hamer

John Hamer

Direktor/Vorstandsmitglied bei
E-Markets, Inc.
68 Jahre
Health Technology
Finance
Commercial Services

Profil

Dr. John E.
Hamer is a Managing Partner, DCVC Bio at DCVC Management Co. LLC and a Director at Golden Pine Ventures LLC.
He is on the Board of Directors at Atomwise, Inc., Nidus Investment Partners LP, BioPhero ApS, E-Markets, Inc., Solu Therapeutics, Inc., Umoja Biopharma, Inc. and Unlearn.AI, Inc. Dr. Hamer was previously employed as an Independent Director by AbCellera Biologics, Inc., a Managing Director by Monsanto Growth Ventures, a Chairman by Chromatin, Inc., a Chief Executive Officer by Arête Therapeutics, Inc., a Managing Director by Burrill & Co. LLC, a Chief Executive Officer & Vice President by Icoria, Inc., a CSO, CEO, VP Business Development by Icoria, Inc., a Professor by Purdue University, and a Chairman by Sentinext Therapeutics Sdn.
Bhd.
He also served on the board at Malaysian Life Sciences Capital Fund Management Co. Ltd., Chlorogen, Inc., Cobalt Technologies, Inc., CropDesign NV and NanoVasc, Inc. He received his undergraduate degree from the University of Windsor, a graduate degree from the University of Windsor and a doctorate degree from the University of California, Davis.

Aktive Positionen von John Hamer

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Private Equity Investor -
Direktor/Vorstandsmitglied -
Private Equity Investor 01.04.2018
Direktor/Vorstandsmitglied 18.06.2021
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von John Hamer

UnternehmenPositionEnde
ABCELLERA BIOLOGICS INC. Direktor/Vorstandsmitglied 07.12.2021
░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von John Hamer im Detail an

Ausbildung von John Hamer

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

80

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen24

Commercial Services

Health Technology

Health Technology

Process Industries

Commercial Services

Finance

Technology Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Finance

Finance

Health Technology

Finance

Finance

Health Technology

Finance

Technology Services

Commercial Services

Technology Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. John Hamer
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT